Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more from just $11.99/month.

    Episode 097: Treatment of Relapsed/Refractory CLL

    UNLIMITED

    Episode 097: Treatment of Relapsed/Refractory CLL

    FromThe Fellow on Call: The Heme/Onc Podcast

    Start listeningView podcast show

    UNLIMITED

    Episode 097: Treatment of Relapsed/Refractory CLL

    FromThe Fellow on Call: The Heme/Onc Podcast

    ratings:
    Length:
    20 minutes
    Released:
    Mar 27, 2024
    Format:
    Podcast episode

    Description

    This week, we continue our discussion of treatment of CLL, this time focusing on the relapsed/refractory CLL. If you have not done so, we recommend checking out our prior episodes since we will be building on these conversations! Content: -If you suspect your patient has relapsed, what do you do? -What is the approach to treatment in the relapsed/refractory setting?- What is Richter's transformation?** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast
    Released:
    Mar 27, 2024
    Format:
    Podcast episode

    Titles in the series (100)

    We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.